Adnan A Kadi

34PUBLICATIONS
14CO-AUTHORS
Characterisation of biological macromoleculesGene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Pharmaceutical delivery technologiesInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 01, 2026
A One-Min, FDA-Validated UPLC-MS/MS Method for the AML Smoothened Inhibitor Glasdegib Quantification and Metabolic Stability Assessment in Human Liver Microsomes: In Silico Metabolic Lability and Toxicity Screening.

|Sep 15, 2026
An Ultra-Fast UPLC-MS/MS Method for Quantifying Ivosidenib: Application to Assessment of Metabolic Stability in Human Liver Microsomes.

|Sep 07, 2026
Quantification of tadalafil in HLMs using an ultrafast UPLC-MS/MS method to assess metabolic stability, including in silico analysis of metabolic lability, DEREK alerts, and ADME characteristics.

|May 14, 2026
Evaluation of vardenafil's metabolic stability in human liver microsomes through ultra-fast UPLC-MS/MS for quantitative analysis, including assessments of greenness, ADME properties, DEREK alerts, and metabolic lability.

|Mar 05, 2026
Quantification of olaparib in human liver microsomes using an ultra-fast UPLC-MS/MS quantitative approach: in vitro and in silico metabolic stability assessment.

Mohamed W Attwa, Haitham AlRabiah, Adnan A Kadi

|Feb 11, 2026
A hydrophilic interaction UPLC-MS/MS quantitative method for the quantification of saracatinib in the human liver microsome matrix and its application in in vitro metabolic stability assessment.

Mohamed W Attwa, Adnan A Kadi

Pageof 6

Frequent Collaborators

31 joint publications

Mohamed W Attwa

16 joint publications

Ali S Abdelhameed

9 joint publications

Haitham AlRabiah

3 joint publications

Awadh M Ali